A prospective study of inflammatory cytokines and diabetes mellitus in a multiethnic cohort of postmenopausal women.
暂无分享,去创建一个
J. Manson | F. Hu | N. Cook | L. Kuller | B. Howard | N. Rifai | G. Heiss | D. Bonds | Simin Liu | G. Hotamisligil | Yiqing Song | L. Tinker | F. Hu
[1] M. Rutter,et al. C-Reactive Protein, the Metabolic Syndrome, and Prediction of Cardiovascular Events in the Framingham Offspring Study , 2004, Circulation.
[2] Ren-Ke Li,et al. A Self-Fulfilling Prophecy: C-Reactive Protein Attenuates Nitric Oxide Production and Inhibits Angiogenesis , 2002, Circulation.
[3] B. Nicklas,et al. The metabolic syndrome in obese postmenopausal women: relationship to body composition, visceral fat, and inflammation. , 2004, The Journal of clinical endocrinology and metabolism.
[4] D. Song,et al. Serum tumor necrosis factor-alpha levels and components of the metabolic syndrome in obese adolescents. , 2004, Metabolism: clinical and experimental.
[5] K. Wellen,et al. Inflammation, stress, and diabetes. , 2005, The Journal of clinical investigation.
[6] S. Coppack,et al. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[7] A. Hofman,et al. Markers of inflammation and cellular adhesion molecules in relation to insulin resistance in nondiabetic elderly: the Rotterdam study. , 2001, The Journal of clinical endocrinology and metabolism.
[8] James T. Willerson,et al. Direct Proinflammatory Effect of C-Reactive Protein on Human Endothelial Cells , 2000, Circulation.
[9] S. Haffner,et al. Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. , 2002, Diabetes.
[10] W. Rathmann,et al. Impaired glucose tolerance is associated with increased serum concentrations of interleukin 6 and co-regulated acute-phase proteins but not TNF-alpha or its receptors. , 2002, Diabetologia.
[11] H. Brenner,et al. Association between C-reactive protein and features of the metabolic syndrome: a population-based study. , 2000, Diabetes care.
[12] T. Funahashi,et al. Inflammatory markers, adiponectin, and risk of type 2 diabetes in the Pima Indian. , 2003, Diabetes care.
[13] C. Stehouwer,et al. Humoral markers of inflammation and endothelial dysfunction in relation to adiposity and in vivo insulin action in Pima Indians. , 2002, Atherosclerosis.
[14] J. Manson,et al. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. , 2001, JAMA.
[15] S. Haffner,et al. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). , 2000, Circulation.
[16] P. Ridker,et al. C-reactive protein levels among women of various ethnic groups living in the United States (from the Women's Health Study). , 2004, The American journal of cardiology.
[17] J. Pickup. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. , 2004, Diabetes care.
[18] C. Meisinger,et al. C-reactive protein as a predictor for incident diabetes mellitus among middle-aged men: results from the MONICA Augsburg cohort study, 1984-1998. , 2003, Archives of internal medicine.
[19] E. Ford. Leukocyte count, erythrocyte sedimentation rate, and diabetes incidence in a national sample of US adults. , 2002, American journal of epidemiology.
[20] K. Suzuki,et al. White blood-cell count and the risk of impaired fasting glucose or Type II diabetes in middle-aged Japanese men , 2002, Diabetologia.
[21] JoAnn E. Manson,et al. Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group. , 1998, Controlled clinical trials.
[22] Gerardo Heiss,et al. Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study , 1999, The Lancet.
[23] S. Coppack,et al. Adipose tissue as an endocrine and paracrine organ , 1998, International Journal of Obesity.
[24] L. Kuller,et al. The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study. , 2001, Diabetes.
[25] Irving Kushner,et al. C-reactive Protein* , 2004, Journal of Biological Chemistry.
[26] R. Prentice,et al. Biostatistical issues and concepts in epidemiologic research. , 1986, Journal of chronic diseases.
[27] Scott Davis,et al. Implementation of the Women's Health Initiative study design. , 2003, Annals of epidemiology.
[28] L. Niskanen,et al. C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men , 2004, Diabetologia.
[29] J S Yudkin,et al. Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1997 by The Endocrine Society Subcutaneous Adipose Tissue Releases Interleukin-6, But Not Tumor Necrosis Factor-�, in Vivo* , 2022 .
[30] J. Pankow,et al. Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study. , 2003, Diabetes.
[31] M. Hanefeld,et al. Subclinical inflammation is strongly related to insulin resistance but not to impaired insulin secretion in a high risk population for diabetes. , 2002, Metabolism: clinical and experimental.
[32] B. Spiegelman,et al. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. , 1993, Science.
[33] W. Rathmann,et al. Impaired glucose tolerance is associated with increased serum concentrations of interleukin 6 and co-regulated acute-phase proteins but not TNF-α or its receptors , 2002, Diabetologia.
[34] Sridevi Devaraj,et al. Demonstration That C-Reactive Protein Decreases eNOS Expression and Bioactivity in Human Aortic Endothelial Cells , 2002, Circulation.
[35] Joachim Spranger,et al. Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. , 2003, Diabetes.
[36] N. Sattar,et al. C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. , 2002, Diabetes.
[37] Z. Bloomgarden. Inflammation, atherosclerosis, and aspects of insulin action. , 2005, Diabetes care.
[38] S. Bandinelli,et al. Diverse Effect of Inflammatory Markers on Insulin Resistance and Insulin‐Resistance Syndrome in the Elderly , 2004, Journal of the American Geriatrics Society.
[39] M. Visser,et al. Prospective relation of C-reactive protein with type 2 diabetes: response to Han et al. , 2003, Diabetes care.
[40] N. Sattar,et al. Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study. , 2002, Diabetes care.
[41] B. Wajchenberg. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. , 2000, Endocrine reviews.
[42] Nader Rifai,et al. Inflammatory markers and risk of developing type 2 diabetes in women. , 2004, Diabetes.
[43] Nancy R Cook,et al. C-Reactive Protein, the Metabolic Syndrome, and Risk of Incident Cardiovascular Events: An 8-Year Follow-Up of 14 719 Initially Healthy American Women , 2003, Circulation.
[44] K. Uysal,et al. Protection from obesity-induced insulin resistance in mice lacking TNF-α function , 1997, Nature.
[45] S. Coppack,et al. Endothelial Dysfunction: Cause of the Insulin Resistance Syndrome , 1997, Diabetes.
[46] J. Flier,et al. Adipose Tissue as an Endocrine Organ , 2014 .
[47] S. Humphries,et al. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? , 2000, Atherosclerosis.